Document is current
Any future updates will be listed below
-
Authors
Zamora, Víctor https://orcid.org/0000-0003-2061-0052
Garin, Olatz https://orcid.org/0000-0001-6193-0779
Suárez, José Francisco https://orcid.org/0000-0001-6427-4391
Jové, Josep https://orcid.org/0000-0003-0196-0372
Castells, Manuel https://orcid.org/0000-0003-2370-2008
Ferrer, Ferran https://orcid.org/0000-0002-3374-0967
Gutiérrez, Cristina https://orcid.org/0000-0002-6944-772X
Guedea, Ferran https://orcid.org/0000-0001-8798-8696
Boladeras, Ana https://orcid.org/0000-0002-2344-8014
Fumadó, Lluis https://orcid.org/0000-0003-3996-167X
Roselló, Alvar https://orcid.org/0000-0002-8298-2890
Pastor, Jorge https://orcid.org/0000-0002-4693-1041
Samper, Pilar https://orcid.org/0000-0002-2020-6431
Pont, Àngels https://orcid.org/0000-0002-0602-552X
Ferrer, Montse https://orcid.org/0000-0001-9867-7391
-
Funding
Funding for this research was provided by:
Instituto de Salud Carlos III (PI21/00023, PI13/00412, PI11/01191, FI19/00229)
Fundación Pública Andaluza para la Gestión de la Investigación en Salud de Sevilla (PI-0102-2011)
Fundación Científica Asociación Española Contra el Cáncer (PRYES223070FERR)
Generalitat de Catalunya (2021 SGR 00624)
Movember Foundation
Universitat Pompeu Fabra
- License Information
-
More Information
Article History
Received: 31 July 2023
Accepted: 10 October 2023
First Online: 10 November 2023
Declarations
:
: Olatz Garin and Montse Ferrer certify that all conflicts of interest including specific financial interests and relationships and affiliations relevant to the subject matter or materials discussed in the manuscript (e.g., employment/affiliation, grants or funding, consultancies, honoraria, stock ownership or options, expert testimony, royalties, or patents filed, received, or pending), are the following: none.
: The present study has been reviewed and approved by the Institutional Review Board at the Hospital del Mar Medical Research Institute, in accordance with the 2000 Declaration of Helsinki. The study was also approved by the ethics committees from the participating sites: Institut Català d’Oncologia-L’Hospitalet, Hospital Regional Universitario de Málaga, Hospital Universitari de Bellvitge, Hospital del Mar, Hospital Provincial de Castellón, Hospital Universitario Central de Asturias, Hospital Universitario Rey Juan Carlos, Hospital Universitario de Salamanca, Hospital General Universitario de Ciudad Real, Institut Català d’Oncologia-Badalona, Hospital Universitario de Navarra, Hospital General Universitario de Valencia, Hospital de la Santa Creu i Sant Pau, Hospital do Meixoeiro, Hospital Universitario Reina Sofía, and Hospital General Universitario de Albacete. Written informed consent was provided by all subjects when they were enrolled.
: Informed consent was obtained from all individual participants included in the study.
